Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.380
-0.020 (-1.43%)
At close: Nov 6, 2026, 4:00 PM EST
1.394
+0.014 (1.04%)
After-hours: Nov 6, 2026, 7:30 PM EST
Pulmatrix Earnings Call Transcripts
Fiscal Year 2026
-
Eight proposals covered the Eos merger, reverse split, authorized shares, auditor, directors, executive pay and incentive plan. Preliminary results showed sufficient votes for the nominees and all other proposals; final totals were to be filed with the SEC.
Fiscal Year 2024
-
Pulmatrix and Cullgen will merge, with Cullgen stockholders owning 96.4% of the combined entity, which will operate under the Cullgen name and focus on targeted protein degraders and DACs. The merger, expected to close by March 2025, brings $65M in cash and a robust clinical pipeline.